The biological materials processed at BC19-Fiocruz follow the quality, biosafety and bioprotection standards determined by national and international standards, in particular ABNT NBR ISO 20387, as well as legal and ethical requirements.
BC19-Fiocruz will initially consist of two collections: Collection of Human Biological Materials and Collection of Viruses.
Collection of Human Biological Material
This collection will initially consist of human biological materials related to Covid-19, mainly blood samples and derivatives and materials used for the laboratory diagnosis of SARS-CoV-2 (oropharyngeal, oral and nasal secretions), from assistance and of research. In compliance with national regulations (Res. CNS 441/2011 and Ordinance MS 2201/2011), BC19-Fiocruz will be accredited as a Biobank of human biological materials for research purposes with the National Commission for Research Ethics (Conep/CNS/MS) . Accreditation of BC19-Fiocruz by the CEP/Conep System in process.
Foto de Raul Santana | Fiocruz Imagens
Virus collection
This Collection will initially consist of isolates of the new SARS-CoV-2 coronavirus, its derivatives and other related biotechnological products, from Fiocruz laboratories and other national and international institutions, in accordance with the requirements established for the Center for Biological Resources (CRB ) and with the requirements and regulations of national and international legislation on Access and Benefit Sharing (Nagoya Protocol, Law 13,123/2015, Decree 8,772/2016).
Foto de Débora Barreto | Fiocruz Imagens